Handelsbanken Fonder AB - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$430
-22.5%
13,6000.0%0.00%
-33.3%
Q2 2023$555
+37.7%
13,600
+25.9%
0.00%
+50.0%
Q1 2023$403
+6.9%
10,8000.0%0.00%0.0%
Q4 2022$377
-99.9%
10,800
+13.7%
0.00%
-50.0%
Q3 2022$532,000
+8.1%
9,5000.0%0.00%
+33.3%
Q2 2022$492,000
-28.7%
9,5000.0%0.00%
-25.0%
Q1 2022$690,000
-48.8%
9,500
-16.7%
0.00%
-42.9%
Q4 2021$1,348,000
-28.2%
11,400
-18.6%
0.01%
-30.0%
Q3 2021$1,878,000
+127.1%
14,000
+35.9%
0.01%
+100.0%
Q1 2021$827,000
+55.2%
10,300
+5.1%
0.01%
+66.7%
Q4 2020$533,0009,8000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders